TC
ADPT icon

TownSquare Capital’s Adaptive Biotechnologies ADPT Stock Holding History

TownSquare Capital’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,818
Closed -$95.2K – 621
2025
Q1 		$95.2K Buy
12,818
+1,793
+16% +$13.8K ﹤0.01% 1627
2024
Q4 		$66.1K Buy
11,025
+7
+0.1% +$39 ﹤0.01% 1533
2024
Q3 		$56.4K Buy
+11,018
New +$48K ﹤0.01% 1456
2023
Q4 		– Sell
-11,949
Closed -$65.1K – 1132
2023
Q3 		$65.1K Sell
11,949
-129
-1% -$853 ﹤0.01% 1068
2023
Q2 		$81K Sell
12,078
-34
-0.3% -$253 ﹤0.01% 1025
2023
Q1 		$107K Buy
12,112
+1,486
+14% +$13.1K ﹤0.01% 937
2022
Q4 		$81.2K Buy
+10,626
New +$82.7K ﹤0.01% 901

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TownSquare Capital's ADPT Position: Q2 2025 in Review

TownSquare Capital sold out of Adaptive Biotechnologies (ADPT) in Q2 2025, closing a stake of 12,818 shares — an estimated $95.2K sold.

TownSquare Capital first reported a position in ADPT in Q4 2022 and held it in 7 quarters. The position peaked at $107K in Q1 2023. 242 funds tracked by Wall St. Rank hold ADPT as of Q2 2025.

  • TownSquare Capital reported no remaining Adaptive Biotechnologies position as of Q2 2025 after selling out during the quarter.
  • TownSquare Capital sold 12,818 Adaptive Biotechnologies shares in Q2 2025, an estimated $95.2K.
  • TownSquare Capital first reported a position in Adaptive Biotechnologies in Q4 2022 and held it in 7 quarters.
  • TownSquare Capital's Adaptive Biotechnologies position peaked at $107K in Q1 2023.
  • 242 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.